These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3656714

  • 1. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M, Ohi H, Watanabe S, Kojima H, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
    [No Abstract] [Full Text] [Related]

  • 2. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
    Ohmori F, Ohi H, Seki M, Watanabe S, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):493-8. PubMed ID: 3656707
    [No Abstract] [Full Text] [Related]

  • 3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 4. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 5. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
    Ohi H, Watanabe S, Seki M, Fujita T, Ohmori F, Hatano M.
    Nephron; 1987 Apr; 46(2):217-8. PubMed ID: 3600936
    [No Abstract] [Full Text] [Related]

  • 6. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S, Ohi H, Seki M, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract] [Full Text] [Related]

  • 7. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 8. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E, Yagüe J, Vives J, Revert L.
    Med Clin (Barc); 1981 Jun 10; 77(1):21-6. PubMed ID: 7253758
    [Abstract] [Full Text] [Related]

  • 9. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF, Richards NP, Powell RJ, Morgan AG.
    Q J Med; 1987 Nov 10; 65(247):895-8. PubMed ID: 3455546
    [Abstract] [Full Text] [Related]

  • 10. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR, Van Es LA.
    Neth J Med; 1982 Nov 10; 25(7):202-7. PubMed ID: 6924073
    [No Abstract] [Full Text] [Related]

  • 11. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A, Montagnino G, Scalia P, Tarantino A.
    Ric Clin Lab; 1980 Nov 10; 10(1):93-7. PubMed ID: 6781054
    [No Abstract] [Full Text] [Related]

  • 12. Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia.
    Edwards KM, Alford R, Gewurz H, Mold C.
    N Engl J Med; 1983 May 12; 308(19):1138-41. PubMed ID: 6835339
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of the nephritic factor and of circulating immune complexes in cryoglobulinemic glomerulonephritis].
    Pertosa G, Vox E, Pastore A, Schena FP.
    Minerva Nefrol; 1979 May 12; 26(3):251-5. PubMed ID: 262262
    [No Abstract] [Full Text] [Related]

  • 14. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 12; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic rapidly progressive glomerulonephritis with C3 nephritic factor and hypocomplementemia.
    Davis CA, McAdams AJ, Wyatt RJ, Forristal J, McEnery PT, West CD.
    J Pediatr; 1979 Apr 12; 94(4):559-63. PubMed ID: 372512
    [Abstract] [Full Text] [Related]

  • 16. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J, Lesavre P.
    Nouv Presse Med; 1979 Jul 07; 8(30):2447-8. PubMed ID: 493036
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Test for C3 nephritic factor activity by immunofixation electrophoresis.
    Koch FJ, Jenis EH, Valeski JE.
    Am J Clin Pathol; 1981 Jul 07; 76(1):63-7. PubMed ID: 6789671
    [Abstract] [Full Text] [Related]

  • 20. Mesangiocapillary glomerulonephritis and persistent hypocomplementemia.
    Cameron JS, Ogg CS, Turner DR, Weller RO, White RH, Glasgow EF, Peters DK, Martin A.
    Perspect Nephrol Hypertens; 1973 Jul 07; 1 Pt 1():541-56. PubMed ID: 4220250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.